Literature DB >> 21120564

Helicobacter pylori seropositivity in fibromyalgia syndrome.

Nuray Akkaya1, Semih Akkaya, Yusuf Polat, Meral Turk, Tufan Turk, Elif Turhal, Fusun Sahin.   

Abstract

Although there are some studies suggesting relation between different types of infection and fibromyalgia syndrome (FM), there is presently no proof that FM is caused by an infection. Helicobacter pylori (HP) infection may cause extragastric manifestations. Inflammation is an important mediator of increased sympathetic nervous system activity and may lead to pain in fibromyalgia patients. In this study, we aimed to investigate the HP seropositivity in fibromyalgia patients compared with controls for possible role of HP infection in FM. Sixty-seven patients with fibromyalgia were evaluated. Two of them were excluded from the study because of high level of acute phase reactants. Sixty-five female patients with fibromyalgia and 41 randomly selected age-matched female healthy controls were enrolled to study. Serum HP IgA and IgG antibodies were measured by enzyme-linked immunosorbent assay technique. Fibromyalgia Impact Questionnaire was assessed in patients and controls. Seropositivity of HP IgG antibody in the fibromyalgia patients was significantly higher than in the control group. No statistically significant differences were found regarding the clinical features between fibromyalgia patients with HP IgG antibody and patients without IgG antibody. Our study suggests that former HP infection may have a role in the etiopathogenesis of fibromyalgia syndrome or may act as a triggering factor. However, high seroprevalence of HP in general population and prevalent asymptomatic infection make it difficult to interpret these results for the definite role of HP in FM. Highlighting the pathophysiologic mechanisms of FM will result in more effective treatment regimens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120564     DOI: 10.1007/s10067-010-1618-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  36 in total

1.  Fibromyalgia syndrome in patients infected with human immunodeficiency virus. The Boston City Hospital Clinical AIDS Team.

Authors:  R W Simms; C A Zerbini; N Ferrante; J Anthony; D T Felson; D E Craven
Journal:  Am J Med       Date:  1992-04       Impact factor: 4.965

2.  Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population.

Authors:  D Us; G Hasçelik
Journal:  J Infect       Date:  1998-09       Impact factor: 6.072

3.  Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests.

Authors:  L Monteiro; A de Mascarel; A M Sarrasqueta; B Bergey; C Barberis; P Talby; D Roux; L Shouler; D Goldfain; H Lamouliatte; F Mégraud
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

4.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

5.  Lyme disease associated with fibromyalgia.

Authors:  H Dinerman; A C Steere
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

6.  Association of Helicobacter pylori infection with systemic inflammation in preeclampsia.

Authors:  Yusuf UstUn; Yaprak Engin-UstUn; Esra Ozkaplan; BariS Otlu; Mehmet Sait TekerekoGlu
Journal:  J Matern Fetal Neonatal Med       Date:  2010-04

7.  Fibromyalgia frequency in hepatitis B carriers.

Authors:  Burhan Adak; Ibrahim Tekeoğlu; Levent Ediz; Mustafa Budancamanak; Turan Yazgan; Kasim Karahocagil; Adnan Demirel
Journal:  J Clin Rheumatol       Date:  2005-06       Impact factor: 3.517

Review 8.  Role of infectious agents in systemic rheumatic diseases.

Authors:  H Amital; M Govoni; R Maya; P L Meroni; B Ori; Y Shoenfeld; A Tincani; F Trotta; P Sarzi-Puttini; F Atzeni
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

Review 9.  Status of immune mediators in fibromyalgia.

Authors:  Ali Gur; Pelin Oktayoglu
Journal:  Curr Pain Headache Rep       Date:  2008-06

10.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

View more
  8 in total

1.  Association between Helicobacter pylori infection and fibromyalgia syndrome.

Authors:  Christos Zavos; Jannis Kountouras; Panagiotis Katsinelos; Stergios A Polyzos; Georgia Deretzi; Nikolaos Zavos; Emmanouel Gavalas; Ioannis Pilpilidis; Dimitrios Tzilves
Journal:  Clin Rheumatol       Date:  2010-12-29       Impact factor: 2.980

Review 2.  Role of Helicobacter pylori infection in autoimmune diseases.

Authors:  Sarfaraz Ahmed Hasni
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

3.  Helicobacter pylori seropositivity in fibromyalgia syndrome.

Authors:  Nuray Akkaya; Semih Akkaya; Yusuf Polat; Meral Turk; Tufan Turk; Elif Turhan; Fusun Sahin
Journal:  Clin Rheumatol       Date:  2011-09-09       Impact factor: 2.980

Review 4.  Extraintestinal manifestations of Helicobacter pylori: a concise review.

Authors:  Frank Wong; Erin Rayner-Hartley; Michael F Byrne
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 5.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 6.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 7.  A systematic review of the association between fibromyalgia and functional gastrointestinal disorders.

Authors:  Sharon Erdrich; Jason A Hawrelak; Stephen P Myers; Joanna E Harnett
Journal:  Therap Adv Gastroenterol       Date:  2020-12-08       Impact factor: 4.409

8.  Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review.

Authors:  Sharon Erdrich; Jason A Hawrelak; Stephen P Myers; Joanna E Harnett
Journal:  BMC Musculoskelet Disord       Date:  2020-03-20       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.